Immunic, Inc.
IMUX· Nasdaq
Released Nov 7, 2018, after the close
10-Q filed Nov 8, 2018, 39 days after period end · 0001280776-18-000104
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Net Income | -$1.80M | -$12.48M | -$10.18M | -$12.30M |
| EPS Diluted | -$2.12 | -$0.30 | -$0.32 | -$0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR